Feasibility Study for the Development of Combination Dosage Form Containing Aspirin and Omeprazole for Treating Cardiovascular and Cerebrovascular Events. Bangla Pharma J. 2025;28(1):105-113. doi:10.3329/bpj.v28i1.79470